← Evidence map

ArticleBlood2022

Impact of CD19 CAR T-cell product type on outcomes in relapsed or refractory aggressive B-NHL.

Jordan Gauthier et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

38 papers cite it

2022
2023
2024
2025
2026
this paperpooled itcites it

The trial

Full record →Abstract, authors, funding and every citing paper · PMID 35439295